Active	Status	Sponsor type	Region	Phase	Filter
6 Active 12 Inactive 18 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other Show only owner-sponsored trials	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

6 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Apokyn (apomorphine bolus injection) / Stada, Supernus Pharma, Aguettant
2010-019198-14: Icke-motoriska och hälsoekonomiska effekter av intermittent subkutan apomorfinbehandling vid Parkinsons sjukdom	Ongoing	4	30	Europe	Apo-GO Pen, Apo-GO Pen, Apo-GO Pen	Karolinska Universitetssjukhuset Huddinge	Parkinsons sjukdom
APOMORPHEE, NCT02940912: Effect of Continuous Apomorphine During the Night on Sleep Disorders in Insomniac Patients With Parkinson's Disease	Completed	4	45	Europe	Apomorphine, Apokinon, Placebo, Physiologic Serum	Clinique Beau Soleil	Parkinson Disease	01/21	04/21
2010-018650-12: Evaluation du système noradrénergique dans l’altération de la perception douloureuse chez le patient Parkinsonien	Ongoing	3	36	Europe	duloxetine, apomorphine, levodopa, dompéridone, CYMBALTA, APOKINON, MODOPAR, MOTILIUM, CYMBALTA, APOKINON, MODOPAR, MOTILIUM	CHU de Toulouse	maladie de Parkinson
2016-002454-20: Apomorphine Pump in Early Stage of Parkinson’s Disease Pompe à apomorphine au stade précoce de la maladie de Parkinson	Ongoing	3	192	Europe	APOKINON, Solution for infusion, APOKINON	CHU de Rennes, CHU de Rennes	Parkinson’s disease Maladie de Parkinson, Parkinson’s disease Maladie de Parkinson, Diseases [C] - Nervous System Diseases [C10]
EARLY-PUMP, NCT02864004: Apomorphine Pump in Early Stage of Parkinson's Disease	Active, not recruiting	3	134	Europe	Apomorphine, Apokinon, Best Medical Treatment	Rennes University Hospital	Parkinson's Disease	12/23	01/25
2004-001929-20: EL TEST DE APOMORFINA COMO MARCADOR BIOLÓGICO DE LAS RECAÍDAS EN PACIENTES DEPENDIENTES DE SUSTANCIAS PSICOTROPAS	Ongoing	2	180	Europe	Ialoprida, APO-go PEN 10 mg/ml solución inyectable, 123I-IBZM, APO-go PEN 10 mg/ml solución inyectable, 123I-IBZM	Servicio de Psiquiatría. Hospital Universitari Vall d’Hebron	Dependencia de alcoholDependencia de cocaínaDependencia de heroína